Thromboxane modulating agents. 4. Design and synthesis of 3-(2-[{(4-chlorophenyl)sulfonyl}amino]ethyl)benzenepropanoic acid derivatives as potent thromboxane receptor antagonists
- 1 August 1998
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 8 (16) , 2061-2066
- https://doi.org/10.1016/s0960-894x(98)00242-x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Thromboxane Modulating Agents. 3. 1H-Imidazol-1-ylalkyl- and 3-Pyridinylalkyl-Substituted 3-[2-[(Arylsulfonyl)amino]ethyl]benzenepropanoic Acid Derivatives as Dual Thromboxane Synthase Inhibitor/Thromboxane Receptor AntagonistsJournal of Medicinal Chemistry, 1997
- Thromboxane modulating agents. 2. Thromboxane receptor antagonists derived from the thromboxane synthase inhibitor dazmegrel.Bioorganic & Medicinal Chemistry Letters, 1996
- Thromboxane modulating agents. 1. Design of 1-[(arylsulfonyl)amino] alkylindole derivatives as dual thromboxane synthase inhibitor/thromboxane receptor antagonists.Bioorganic & Medicinal Chemistry Letters, 1995
- Recent progress in the clinical development of thromboxane A2receptor antagonistsExpert Opinion on Investigational Drugs, 1994
- Novel antithrombotic agents with combined thromboxane receptor antagonist (TxRA)/thromboxane synthase inhibitor (TxSI) activitiesDrugs of the Future, 1994
- Thromboxane A2 receptor antagonistsMedicinal Research Reviews, 1991
- Thromboxane-A2/prostaglandin-H2 receptors: Characterization and antagonismTrends in Cardiovascular Medicine, 1991
- The biochemical pharmacology of thromboxane synthase inhibition in man.Circulation, 1985
- Selective thromboxane synthetase inhibitors. 1. 1-[(Aryloxy)alkyl]-1H-imidazolesJournal of Medicinal Chemistry, 1985